UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways

Cell, 2014-10, Vol.159 (3), p.499-513

2014

Volltextzugriff (PDF)

Imaging neuroinflammation with TSPO: A new perspective on the cellular sources and subcellular localization

Pharmacology & therapeutics (Oxford), 2022-06, Vol.234, p.108048-108048, Article 108048

2022

Volltextzugriff (PDF)

Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b-Mediated Malignant Progression

Cancer research (Chicago, Ill.), 2016-01, Vol.76 (2), p.491-504

2016

Volltextzugriff (PDF)

Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells

Clinical cancer research, 2018-10, Vol.24 (19), p.4874-4886

2018

Volltextzugriff (PDF)

Surface translocator protein 18 kDa (TSPO) localization on immune cells upon stimulation with LPS and in ART‐treated HIV+ subjects

Journal of leukocyte biology, 2021-07, Vol.110 (1), p.123-140

2021

Volltextzugriff (PDF)

Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancers

Nature medicine, 2024-04, Vol.30 (4), p.990-1000

2024

Volltextzugriff (PDF)

A Novel Interaction of Translocator Protein 18 kDa (TSPO) with NADPH Oxidase in Microglia

Molecular neurobiology, 2020-11, Vol.57 (11), p.4467-4487

2020

Volltextzugriff (PDF)

A New Role for ERα: Silencing via DNA Methylation of Basal, Stem Cell, and EMT Genes

Molecular cancer research, 2017-02, Vol.15 (2), p.152-164

2017

Volltextzugriff (PDF)

The Western Australian Audit of Surgical Mortality: outcomes from the first 10 years

Medical journal of Australia, 2013-10, Vol.199 (8), p.539-542

2013

Volltextzugriff (PDF)

Ovarian Cancer Treatment Stratification Using Ex Vivo Drug Sensitivity Testing

Anticancer research, 2019-08, Vol.39 (8), p.4023-4030

2019

Volltextzugriff (PDF)

The Translocator Protein ( TSPO ) Genetic Polymorphism A147T Is Associated with Worse Survival in Male Glioblastoma Patients

Cancers, 2021-09, Vol.13 (18), p.4525

2021

Volltextzugriff (PDF)

Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in γ‐secretase inhibitor drug responses

EMBO molecular medicine, 2013-10, Vol.5 (10), p.1502-1522

2013

Volltextzugriff (PDF)

Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures

Breast cancer research and treatment, 2014-04, Vol.144 (3), p.503-517

2014

Volltextzugriff (PDF)

Clinical Utility of Functional Precision Medicine in the Management of Recurrent/Relapsed Childhood Rhabdomyosarcoma

JCO precision oncology, 2021, Vol.5 (5), p.1659-1665

2021

Volltextzugriff (PDF)

DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer

Clinical cancer research, 2022-05, Vol.28 (9), p.1948-1965

2022

Volltextzugriff (PDF)

Surface Translocator Protein 18 kDa (TSPO) localization on immune cells upon stimulation with lipopolysaccharide and in ART-treated HIV+ subjects

Journal of leukocyte biology, 2020-11, Vol.110 (1), p.123-140

2020

Volltextzugriff (PDF)

Programmed cell death in the lithium pilocarpine model: Evidence for NMDA receptor and ceramide-mediated mechanisms

Brain & development (Tokyo. 1979), 2008-09, Vol.30 (8), p.513-519

2008

Volltextzugriff (PDF)

Abstract 1906: The role of immunogenic SPANX antigens in distinct cancer stem cell subsets within triple negative breast cancers

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1906-1906

2017

Volltextzugriff (PDF)

High-performance liquid chromatography method for quantifying sphingomyelin in rat brain

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007-11, Vol.859 (1), p.131-136

2007

Volltextzugriff (PDF)

ERK/MAPK regulation of the androgen responsiveness of breast cancer cells

Advances in experimental medicine and biology, 2008, Vol.617, p.429

2008

Volltextzugriff (PDF)

Clinical utility and accessibility of functional precision medicine for relapsed/refractory pediatric and adult cancers

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.1551-1551

2024

Volltextzugriff (PDF)

Abstract B50: Preclinical efficacy of combined MEK and Src inhibition: MEK inhibitor reverses resistance to Src inhibitor therapy in ovarian cancer cells

Clinical cancer research, 2013-10, Vol.19 (19_Supplement), p.B50-B50

2013

Volltextzugriff (PDF)

Ex-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot study

Leukemia research, 2018-01, Vol.64, p.34-41

2018

Volltextzugriff (PDF)

Abstract 3042: Therapeutic targeting of distinct subsets of cancer stem cells within triple negative breast cancers

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3042-3042

2014

Volltextzugriff (PDF)

Src Inhibition with Saracatinib Reverses Fulvestrant Resistance in ER-Positive Ovarian Cancer Models In Vitro and In Vivo

Clinical cancer research, 2012-11, Vol.18 (21), p.5911-5923

2012

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(40)

Publikationsform

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways

Imaging neuroinflammation with TSPO: A new perspective on the cellular sources and subcellular localization

Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b-Mediated Malignant Progression

Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells

Surface translocator protein 18 kDa (TSPO) localization on immune cells upon stimulation with LPS and in ART‐treated HIV+ subjects

Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancers

A Novel Interaction of Translocator Protein 18 kDa (TSPO) with NADPH Oxidase in Microglia

A New Role for ERα: Silencing via DNA Methylation of Basal, Stem Cell, and EMT Genes

The Western Australian Audit of Surgical Mortality: outcomes from the first 10 years

Ovarian Cancer Treatment Stratification Using Ex Vivo Drug Sensitivity Testing

The Translocator Protein ( TSPO ) Genetic Polymorphism A147T Is Associated with Worse Survival in Male Glioblastoma Patients

Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in γ‐secretase inhibitor drug responses

Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures

Clinical Utility of Functional Precision Medicine in the Management of Recurrent/Relapsed Childhood Rhabdomyosarcoma

DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer

Surface Translocator Protein 18 kDa (TSPO) localization on immune cells upon stimulation with lipopolysaccharide and in ART-treated HIV+ subjects

Programmed cell death in the lithium pilocarpine model: Evidence for NMDA receptor and ceramide-mediated mechanisms

Abstract 1906: The role of immunogenic SPANX antigens in distinct cancer stem cell subsets within triple negative breast cancers

High-performance liquid chromatography method for quantifying sphingomyelin in rat brain

ERK/MAPK regulation of the androgen responsiveness of breast cancer cells

Clinical utility and accessibility of functional precision medicine for relapsed/refractory pediatric and adult cancers

Abstract B50: Preclinical efficacy of combined MEK and Src inhibition: MEK inhibitor reverses resistance to Src inhibitor therapy in ovarian cancer cells

Ex-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot study

Abstract 3042: Therapeutic targeting of distinct subsets of cancer stem cells within triple negative breast cancers

Src Inhibition with Saracatinib Reverses Fulvestrant Resistance in ER-Positive Ovarian Cancer Models In Vitro and In Vivo

Suchergebnisse filtern